Modulatory Contribution of Oxygenating Hydrogels and Polyhexamethylene Biguanide on the Antimicrobial Potency of Neutrophil-like Cells
Source abstract
Abstract
Neutrophils are a first line of host defense against infection and utilize a series of oxygen-dependent processes to eliminate pathogens. Research suggests that oxygen availability can improve anti-infective mechanisms by promoting the formation of reactive oxygen species. Also, oxygen can synergistically upregulate the antibacterial properties of certain antibiotics against bacteria by altering their metabolism and causing an increase in the antibiotic uptake of bacteria. Therefore, understanding the effects of oxygen availability, as provided via a biomaterial treatment alone or along with potent antibacterial agents, on neutrophil functions can lead us to the development of new anti-inflammatory and anti-infective approaches. However, the study of neutrophil functions in vitro is often limited by their short life span and nonreproducibility, which suggests the need for cell line-based models as a substitute for primary neutrophils. Here, we took advantage of the differentiated human leukemia-60 cell line (HL-60), as an in vitro neutrophil model, to test the effects of local oxygen and antibacterial delivery by fluorinated methacrylamide chitosan (MACF) hydrogels incorporated with polyhexamethylene biguanide (PHMB) antibacterial agent. Considering the natural modes of neutrophil actions to combat bacteria, we studied the impact of our dual functioning oxygenating-antibacterial platforms on neutrophil phagocytosis and antibacterial properties as well as the formation of neutrophil extracellular traps (NETs) and reactive oxygen species (ROS). Our results demonstrated that supplemental oxygen and antibacterial delivery from MACF–PHMB hydrogel platforms upregulated neutrophil antibacterial properties and ROS production. NET formation by neutrophils upon treatment with MACF and PHMB varied when chemical and biological stimuli were used. Overall, this study presents a model to study immune responses in vitro and lays the foundation for future studies to investigate if similar responses also occur in vivo.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Medical and Biological Ozone Research · Diabetic Foot Ulcer Assessment and Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical, Biomolecular and Corrosion Engineering, University of Akron, Akron, Ohio 44325-3906, United States of America
Department of Biomedical Engineering, University of Akron, Akron, Ohio 44325-3906, United States of America
Funding
National Institutes of Health
References (68)
Show source-provided references
1. 10.1089/wound.2012.038310.1089/wound.2012.0383 ↗
2. 10.1038/nri.2017.10510.1038/nri.2017.105 ↗
3. 10.1016/j.it.2019.05.00110.1016/j.it.2019.05.001 ↗
4. 10.3390/ijms2104118310.3390/ijms21041183 ↗
5. 10.1038/s41598-018-29659-110.1038/s41598-018-29659-1 ↗
6. 10.1016/j.biopha.2018.10.14210.1016/j.biopha.2018.10.142 ↗
7. 10.1016/j.actbio.2016.03.02210.1016/j.actbio.2016.03.022 ↗
8. 10.1002/jbm.a.3607910.1002/jbm.a.36079 ↗
9. 10.1007/s10439-017-1893-610.1007/s10439-017-1893-6 ↗
10. 10.1159/00049316210.1159/000493162 ↗
11. 10.1089/wound.2018.088710.1089/wound.2018.0887 ↗
12. 10.1002/adbi.20190025010.1002/adbi.201900250 ↗
13. 10.1371/journal.pone.020337110.1371/journal.pone.0203371 ↗
14. 10.1021/acsami.1c1996210.1021/acsami.1c19962 ↗
15. Yazar E. · Revue de Médecine Vétérinaire · 2001 · 152 · 235
16. 10.1016/j.bbrc.2004.03.08510.1016/j.bbrc.2004.03.085 ↗
17. 10.3109/0892397090305936910.3109/08923970903059369 ↗
18. 10.1038/s41598-020-78854-610.1038/s41598-020-78854-6 ↗
19. 10.1186/s12952-017-0067-210.1186/s12952-017-0067-2 ↗
20. 10.4049/jimmunol.100067510.4049/jimmunol.1000675 ↗
21. 10.1016/j.actbio.2012.10.03410.1016/j.actbio.2012.10.034 ↗
22. 10.1016/j.pnmrs.2010.05.00110.1016/j.pnmrs.2010.05.001 ↗
23. 10.1021/acsabm.9b0083310.1021/acsabm.9b00833 ↗
24. 10.14227/DT190112P610.14227/DT190112P6 ↗
25. 10.1016/j.lfs.2013.06.00310.1016/j.lfs.2013.06.003 ↗
26. 10.2478/v10042-008-0080-x10.2478/v10042-008-0080-x ↗
27. 10.1016/j.immuni.2016.02.02610.1016/j.immuni.2016.02.026 ↗
28. 10.1016/j.chom.2010.10.00510.1016/j.chom.2010.10.005 ↗
29. 10.1371/journal.pone.008470410.1371/journal.pone.0084704 ↗
30. 10.3389/fimmu.2020.0174910.3389/fimmu.2020.01749 ↗
31. 10.1007/s00424-020-02482-210.1007/s00424-020-02482-2 ↗
32. Abri, S. Development of Synergistic Oxygenating Antibacterial Hydrogel Dressings for Reducing Infection in Diabetic Dermal Wounds. Ph.D. Dissertation, The University of Akron, 2022.
33. 10.3390/molecules2503053810.3390/molecules25030538 ↗
34. 10.3389/fmicb.2020.62253410.3389/fmicb.2020.622534 ↗
35. 10.1203/PDR.0b013e3181a9eafb10.1203/PDR.0b013e3181a9eafb ↗
36. 10.1007/s00441-017-2785-710.1007/s00441-017-2785-7 ↗
37. 10.1016/j.it.2010.05.00610.1016/j.it.2010.05.006 ↗
38. 10.1039/D0TB00885K10.1039/D0TB00885K ↗
39. 10.1016/j.actbio.2020.01.01710.1016/j.actbio.2020.01.017 ↗
40. 10.1016/j.biomaterials.2018.08.03210.1016/j.biomaterials.2018.08.032 ↗
41. 10.1016/j.ijbiomac.2015.12.07610.1016/j.ijbiomac.2015.12.076 ↗
42. 10.1002/adfm.20200645310.1002/adfm.202006453 ↗
43. 10.1016/j.heliyon.2020.e0345110.1016/j.heliyon.2020.e03451 ↗
44. 10.22270/jddt.v12i2-S.540210.22270/jddt.v12i2-S.5402 ↗
45. 10.1007/s11626-008-9163-410.1007/s11626-008-9163-4 ↗
46. Tardif M. · J. Immunol. · 1998 · 161 · 688510.4049/jimmunol.161.12.6885 ↗
47. Solary E. · Leukemia · 1994 · 8 · 792
48. 10.1006/excr.2001.520010.1006/excr.2001.5200 ↗
49. 10.1042/BSR2011010910.1042/BSR20110109 ↗
50. 10.1038/cr.1995.1710.1038/cr.1995.17 ↗
51. 10.1016/j.yexcr.2016.03.00710.1016/j.yexcr.2016.03.007 ↗
52. Haslett C. · Am. J. Pathol. · 1985 · 119 · 101
53. 10.1172/JCI10895910.1172/JCI108959 ↗
54. 10.3389/fcimb.2017.0037310.3389/fcimb.2017.00373 ↗
55. 10.1590/S0100-879X201200750012310.1590/S0100-879X2012007500123 ↗
56. 10.1007/978-981-15-0263-7_1510.1007/978-981-15-0263-7_15 ↗
57. 10.1081/ESE-12000599310.1081/ESE-120005993 ↗
58. 10.1016/j.aoas.2013.01.00610.1016/j.aoas.2013.01.006 ↗
59. 10.1189/jlb.091246210.1189/jlb.0912462 ↗
60. 10.1111/imm.1332010.1111/imm.13320 ↗
61. 10.1002/9781119436812.ch5610.1002/9781119436812.ch56 ↗
62. 10.1016/j.tiv.2016.10.00610.1016/j.tiv.2016.10.006 ↗
63. 10.1371/journal.pone.009141510.1371/journal.pone.0091415 ↗
64. 10.3389/fimmu.2016.0051810.3389/fimmu.2016.00518 ↗
65. 10.1155/2012/84913610.1155/2012/849136 ↗
66. 10.1016/j.bbrc.2011.08.05210.1016/j.bbrc.2011.08.052 ↗
67. 10.1159/00036369910.1159/000363699 ↗
68. 10.1371/journal.ppat.100361410.1371/journal.ppat.1003614 ↗